Retinoblastoma is a rare cancer of the retina (the innermost layer of the eye, located at the back of the eye, that receives light and images necessary for vision). About 300 children will be diagnosed with retinoblastoma this year. It accounts for 3 percent of childhood cancers. Nearly all children with retinoblastoma can be cured of the disease if it has been diagnosed early enough, and 90 percent will have normal vision in at least one eye after treatment.
Retinoblastoma occurs due to mutations in a tumor suppressor gene (called RB1) located on chromosome #13. Two mutations (or gene changes) are necessary to "knock-out" this gene, and cause uncontrolled cell growth. In inherited retinoblastoma (40 percent of the cases), the first mutation is inherited from a parent, while the second occurs during the development of the retina. In sporadic retinoblastoma (60 percent of the cases), both mutations occur during development of the retina. Sporadic means occurs by chance. Alterations in the RB1 gene have also been found in other tumors, including osteosarcoma and breast cancer.
Most children with inherited retinoblastoma have tumors involving both eyes. Consider the following statistics:
60 percent to 75 percent of retinoblastoma cases involve one eye (unilateral), and the majority of these are not inherited.
25 percent of retinoblastoma cases are bilateral (both eyes) and hereditary.
15 percent of retinoblastoma cases are unilateral (one eye) and hereditary.
Any individual with a positive family history of retinoblastoma may want to seek genetic counseling to identify the specific risks of passing the gene or disease to their children.
The following are the most common symptoms of retinoblastoma. However, each child may experience symptoms differently. Symptoms may include:
Leukocoria. A white light reflex that occurs at certain angles when a light is shined into the pupil.
Strabismus (also called wandering eye or lazy-eye). A misalignment of the eyes; when one or both eyes do not appear to be "looking" in the same direction.
Pain or redness around, and swelling of the eye(s)
Poor vision or change in child's vision
Often the symptoms may not appear if the disease is diagnosed early. The symptoms of retinoblastoma may resemble other conditions or medical problems. Always consult your child's doctor for a diagnosis.
In addition to a complete medical and physical examination, diagnostic procedures for retinoblastoma may include:
Complete eye examination and medical history
Funduscopic examination. With the child under anesthesia, the pupils are dilated so the entire retina can be viewed and examined.
Ultrasound exam of the eye. This is one of the most commonly used tests to confirm diagnosis, using sound waves to create images of tissues.
Computed tomography scan (also called a CT or CAT scan). A diagnostic imaging procedure that uses a combination of x-rays and computer technology to produce horizontal, or axial, images (often called slices) of the body. A CT scan shows detailed images of any part of the body, including the bones, muscles, fat, and organs. CT scans are more detailed than general X-rays.
Magnetic resonance imaging (MRI). A diagnostic procedure that uses a combination of large magnets, radiofrequencies, and a computer to produce detailed images of organs and structures within the body without the use of X-rays.
Lumbar puncture (spinal tap)
Genetic and/or DNA testing
A diagnosis may be made before symptoms are present. If a family history is positive for retinoblastoma, frequent eye examinations may be necessary at many stages of the child's development to determine the presence of any tumor. When retinoblastoma is diagnosed, tests will be performed to determine the size of the tumor, and if the tumors have spread to the other parts of the body. This is called staging and is an important step toward planning a treatment program.
There are various staging systems that can be used for retinoblastoma. Always consult your child's physician for more information on staging.
The newest staging method is called The International Classification for Intraocular Retinoblastoma and it groups tumors into five categories--groups A through E--based on the likelihood of saving the eye.
The more traditional method of staging is the Reese-Ellsworth stages of retinoblastoma (this staging system is only for tumors that have not spread beyond the eye):
Group I. One or more tumors that are less than 4 disc diameters (DD) in size and are all located at or behind the equator*.
Group II. Either one or more tumors that are 4 to 10 DD in size located at or behind the equator.
Group III. Any lesion in front of the equator or one tumor larger than 10 DD behind the equator.
Group IV. Multiple tumors with some or all greater than 10 DD in size, or any lesions that extend forward to the ora serrata (front edge of the retina).
Group V. Very large tumors involving more than half of the retina or that have spread into the vitreous (the gelatinous material that fills the eye).
*The "equator" is an imaginary line that divides the eye into two equal parts: a front half and a back half.
Specific treatment for retinoblastoma will be determined by your child's doctor based on:
Your child's age, health, and medical history
Extent of the disease
Your child's tolerance for specific medications, procedures, or therapies
Expectations for the course of the disease
Your opinion or preference
The primary goal of treatment is to remove the tumor and prevent metastasis (spreading) of the cancer to other parts of the body.
Treatment may include one or more of the following:
Enucleation (surgical removal of the eye or eyes involved with the tumor)
Laser therapy or photocoagulation
Cryotherapy (uses a freezing process to destroy the tumor)
Prognosis greatly depends on the following:
The extent of the disease
The size and location of the tumor
Presence or absence of metastasis
The tumor's response to therapy
The age and overall health of your child
Your child's tolerance of specific medications, procedures, or therapies
New developments in treatment
As with any cancer, prognosis and long-term survival can vary greatly from child to child. Every child is unique and treatment and prognosis is structured around the child's needs. Prompt medical attention and aggressive therapy are important for the best prognosis.
Continuous follow-up care is essential for a child diagnosed with retinoblastoma. In hereditary retinoblastoma, new tumors may form in either eye until the child is 3 to 4 years old. Children will need very close follow-up by an ophthalmologist. Children with hereditary retinoblastoma and those treated with some chemotherapies, radiation therapies, and some other therapies, are at higher risk for new cancers later in life and should have regular medical and eye exams.